How much does Unilabs Limited make?

Unilabs Limited reported revenue of £18.7m and a loss of £4.1m in the year to 31 Dec 2024, according to its accounts filed at Companies House.

How many employees does Unilabs Limited have?

Unilabs Limited reported an average of 129 employees in the year to 31 Dec 2024.

Is Unilabs Limited profitable?

No — Unilabs Limited reported a loss of £4.1m in the year to 31 Dec 2024.

Company No. 04115820 · Incorporated 28 Nov 2000

Unilabs Limited

Registered name: UNILABS LIMITED

Part of Unilabs Laboratoire D Analyses Medicales group

Unilabs Limited made £18.7m revenue and a £4.1m loss in the year to 31 Dec 2024.

Unilabs Limited’s revenue grew 8% to £18.7m in the year to 31 Dec 2024, with a loss of £4.1m and 129 employees. The company is classified under “other human health activities” and is based in Manchester; we hold 3 years of its filed accounts.

Full P&L filedSection Q · Human health and social workSIC 86900Other human health activities

Status: In Administration
Location: Manchester, North West
Age: 25 yrs · since 2000
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2024

Key figures

Revenue

£18.7m

Growth ▲7.6%

Profit

−£4.1m

Growth —

Profit margin

−21.9%

Gross 33.5%

Employees

129

Change ▲4.9%

Profit / employee

−£31.8k

Revenue/employee £145k

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£15.4m	£17.4m	£18.7m
Cost of sales	£9.7m	£10.9m	£12.4m
Gross profit	£5.7m	£6.5m	£6.3m
Operating profit	−£2.3m	−£2.2m	−£3.9m
Profit before tax	−£2.2m	−£2.5m	−£4.3m
Profit after tax	−£2.7m	−£2.4m	−£4.1m
Profit (best available)	−£2.7m	−£2.4m	−£4.1m
Staff costs	£7.2m	£7.1m	£8.7m
Employees (average)	94	123	129
Ratios
Profit margin	−17.6%	−13.6%	−21.9%
Gross margin	37.2%	37.4%	33.5%
Revenue per employee	£164k	£141k	£145k
Profit per employee	−£28.8k	−£19.2k	−£31.8k
Growth (year on year)
Revenue growth	—	▲12.9%	▲7.6%
Headcount growth	—	▲30.9%	▲4.9%
Balance sheet — indirect signals, not revenue
Cash at bank	£2.1k	£2.2k	£1.7k
Net assets	£3.5m	£1.1m	−£3.7m
Fixed assets	£4.1m	£3.4m	£2.2m
Current assets	£9.9m	£9.5m	£6.8m
Debtors	£3.3m	£3.2m	£2.6m
Deferred income	£2m	£1.9m	£2.2m
Source	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: −21.9%; Profit ÷ revenue.
Gross margin: 33.5%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £145k; Revenue ÷ average employees.
Profit per employee: −£31.8k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 11.8%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 11.8%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 13.9%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▼437%; Now −£3.7m
Cash at bank: ▼21%; Now £1.7k
Headcount: ▲5%; Now 129
Deferred income: ▲18%; Now £2.2m
Fixed assets: ▼35%; Now £2.2m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Unilabs Laboratoire D Analyses Medicales (registered outside the UK register)ultimate parent75–100%
Unilabs Holding Limited75–100%
Unilabs Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (1)

Independent Histopathology Services LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2024 (profit −£4.1m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.